Located in the heart of downtown San Antonio, CHRISTUS Children’s, owned by CHRISTUS Santa Rosa Health System, provides inpatient care to approximately 5,000 children, 80,000 emergency department ...
Since 2016, CHRISTUS Santa Rosa Hospital - New Braunfels (CSRH-NB) has functioned as a Baby-Friendly facility. The global ...
The risks of adverse effects and complications from treatment for prostate cancer are substantial and continue for years after treatment ends.
Santa Rosa police said they arrested a student at Elsie Allen High School after they were found carrying a gun and ammunition Thursday afternoon. The National Weather Service issued a Fire Weather ...
In February 2013, Baylor College of Medicine and Texas Children’s Hospital entered into a partnership with CHRISTUS Santa Rosa Health System to develop San Antonio’s only freestanding children’s ...
As part of the Northern California Behavioral Health System, we are dedicated to kindness, service, and healing. We offer inpatient psychiatric care in a comfortable, supportive environment.
That’s because Christus teamed up with Shriners to open a pediatric specialty clinic at Christus Good Shepherd Medical Center in Marshall. With the cutting of the ribbon, the clinic was officially ...
Davis, CHRISTUS Santa Rosa Hospital-San Marcos, Ascension Seton Highland Lakes, Ascension Seton Southwest, Coryell Memorial Hospital and Saint Marks Medical Center. Their office accepts new ...
Paola Rosa-Aquino was previously a science reporter at Insider. See how our seasons come from Earth's tilt and yearly loop around the sun, which changes the ice cover, vegetation, and sunlight ...
Christus Health Ark-La-Tex, part of Irving, Texas-based Christus Health, has completed its purchase of Dallas-based Steward Health Care's Wadley Regional Medical Center in Texarkana, Texas ...
Seymour the pumpkin helped grower Brandon Dawson earn a hefty honor at the Half Moon Bay competition. A Santa Rosa man vying for the top prize Monday at the Safeway World Championship Pumpkin ...
Monte Rosa Therapeutics (GLUE) announced a global exclusive development and commercialization license agreement with Novartis (NVS) to advance VAV1 MGDs, including MRT-6160. MRT-6160 is currently ...